Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials

Fig. 4

Pooled results for successful rate of achieving optimal target. Pooled ORs and 95% CrI for all possible head-to-head comparisons regarding the successful rate of achieving optimal target for patients with MM (A) and NHL (B). OR, odds ratio. 95% CrI, 95% credibility interval. CY, cyclophosphamide; FD, fixed dose; G-CSF, granulocyte colony-stimulating factor; ID-AraC, intermediate-dose cytarabine; RD, reduced dose; SD, standard dose; YF-H-2015005, a new CXCR4 antagonist

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512